Review finds sodium supplements linked with growth and less low sodium in preterm infants
The analysis also reports substantial variation between studies and limited evidence about long-term development.
High evidenceReviewInterpret with caution
Medical disclaimer: This article summarizes research findings and is for informational purposes only. It is not medical advice.
Editorial illustration — not from the study.
The researchers combined findings from randomized trials and observational studies to examine growth, blood sodium levels, and neurodevelopment in preterm infants. The analysis found an association between sodium supplementation and improved weight gain, along with a lower reported risk of hyponatremia, or low blood sodium.
The findings require careful interpretation. Rates of high blood sodium and intraventricular hemorrhage were reported among supplemented groups, but these were mainly descriptive frequencies rather than comparisons with unsupplemented groups. Only one study followed infants long enough to report neurodevelopmental outcomes, so any possible developmental benefit remains uncertain and exploratory.
The question reviewed
Researchers conducted a systematic review and meta-analysis of published studies identified through PubMed, Embase, Scopus, and Google Scholar. The studies included infants born before 37 weeks of gestation and examined sodium supplementation in relation to growth, electrolyte balance, and neurodevelopment. Twelve studies with more than 2,800 participants were analyzed using statistical models designed to account for differences between studies. The review included both randomized controlled trials and observational studies.
Key conclusions
Sodium supplementation was associated with improved weight gain and a lower risk of hyponatremia. The reported relative risk of hyponatremia was 0.28, with a 95% confidence interval from 0.08 to 0.96. Among supplemented cohorts, the pooled incidence estimates were 32% for hypernatremia, or high blood sodium, and 29% for intraventricular hemorrhage, bleeding into the fluid-filled spaces of the brain. These latter figures were largely descriptive and were not reliable estimates of risk caused by supplementation because comparative risk data were limited. Only one study reported long-term neurodevelopmental follow-up, and it suggested a possible benefit; this evidence was described as limited and hypothesis-generating.
Where this may apply
The findings may be relevant to preterm infants similar to those included in the reviewed studies, but the abstract does not establish that they apply equally to all preterm infants or to specific clinical circumstances. They do not directly apply to full-term infants, older children, or adults. Because this was a review of mixed evidence and not a single uniform clinical trial, the results should be understood as a summary of associations and limited comparative findings rather than as definitive effects for every patient.
What this could mean
Maintaining appropriate sodium levels and supporting growth are important issues in the care of preterm infants. This review summarizes evidence suggesting that sodium supplementation may be associated with better weight gain and less hyponatremia in this population. It does not establish that supplementation caused these outcomes, determine the effects of particular supplementation strategies, or provide strong evidence about long-term neurodevelopment.
Limitations & evidence assessment
The review combined randomized and observational studies, which can differ in design and susceptibility to bias. There was substantial heterogeneity between studies, and comparative risk estimates were limited for hypernatremia and intraventricular hemorrhage. Only one study reported long-term neurodevelopmental outcomes, making that evidence especially uncertain. The abstract does not provide enough information to assess the quality of each included study, the exact supplementation strategies, or how the participants were distributed across study types.
Why this evidence level: Meta-analysis pooling multiple studies sits at the top of common evidence hierarchies.
Evidence levels are editorial estimates derived from study metadata — they are not clinical appraisals.
This review examined human clinical evidence about GLP-1 receptor agonists and neovascular age-related macular degeneration, sometimes called wet age-related macular degeneration, in people with type 2 diabetes. The reviewed studies had conflicting results: one reported higher risk, another lower risk, and two large comparisons found no significant increase. The evidence is observational and does not show that these medicines cause or prevent the eye condition.
A prospective, multicenter phase II trial examined whether removing only the treated tumor area through the anus could preserve the rectum in people with locally advanced rectal cancer who responded well to chemoradiotherapy. Among 80 participants, three-year disease-free survival was 84.8%, and local recurrence occurred in 5.0% during the reported follow-up. Because everyone received local excision and there was no comparison group, the findings do not establish that this approach is as effective as more extensive surgery.
This retrospective human study compared a visual CT scoring method with an automated computer analysis for tracking fibrosing interstitial lung disease. Among 92 people followed with CT scans and lung-function tests, both approaches were associated with changes in lung function and signs of disease progression. The study does not show that either method improves treatment or patient outcomes.
